Patient centered experiences in breast cancer: predicting long-term adherence to tamoxifen use.
about
Treating Elderly Patients With Hormone Receptor-Positive Advanced Breast CancerCapturing patients' experiences to change Parkinson's disease care delivery: a multicenter studyEndocrine therapy use among elderly hormone receptor-positive breast cancer patients enrolled in Medicare Part DA systematic review of evidence on the links between patient experience and clinical safety and effectivenessPredicting Adherence to Aromatase Inhibitor Therapy among Breast Cancer Survivors: An Application of the Protection Motivation Theory.American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.Financial incentives for quality in breast cancer care.Assessing Patient-Centered Communication in Cancer Care: Measures for Surveillance of Communication OutcomesA hard pill to swallow: a qualitative study of women's experiences of adjuvant endocrine therapy for breast cancer.Influence of patient and treatment factors on adherence to adjuvant endocrine therapy in breast cancerOptimizing adherence to adjuvant imatinib in gastrointestinal stromal tumor.Adherence evaluation of endocrine treatment in breast cancer: methodological aspects.Modeling hot flushes and quality of life in breast cancer survivorsThe effect of complications on the patient-surgeon relationship after colorectal cancer surgery.Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer.Patient adherence to aromatase inhibitor treatment in the adjuvant setting.How can we best respect patient autonomy in breast cancer treatment decisions?Examining the role of patient experience surveys in measuring health care quality.Exemestane in the adjuvant treatment of breast cancer in postmenopausal women.Patients' self-reported adherence to capecitabine on XELOX treatment in metastatic colorectal cancer: findings from a retrospective cohort analysis.Factors affecting length of stay in forensic hospital setting: need for therapeutic security and course of admissionRacial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer.Supporting adherence to oral anticancer agents: clinical practice and clues to improve care provided by physicians, nurse practitioners, nurses and pharmacists.Symptoms and QOL as Predictors of Chemoprevention Adherence in NRG Oncology/NSABP Trial P-1.Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancerStructural equation modeling of the proximal-distal continuum of adherence drivers.Chemotherapy use and patient treatment preferences in advanced colorectal cancer: a prospective cohort studyAdherence to adjuvant hormone therapy in low-income women with breast cancer: the role of provider-patient communicationPerceptions, Attributions, and Emotions Toward Endocrine Therapy in Young Women with Breast Cancer.The challenge of quality in breast care: beyond accreditation.Racial/ethnic differences in use and duration of adjuvant hormonal therapy for breast cancer in the women's health initiativeAdherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review.Medication taking behaviors among breast cancer patients on adjuvant endocrine therapy.Adjuvant endocrine therapy initiation and persistence in a diverse sample of patients with breast cancer.Quality monitoring of physicians: linking patients' experiences of care to clinical quality and outcomes.Pretreatment predictors of short-term nonadherence to oral hormonal therapy for women with breast cancer.Factors associated with compliance to adjuvant hormone therapy in Black and White women with breast cancerEndocrine therapy initiation among Medicaid-insured breast cancer survivors with hormone receptor-positive tumors.A tracking and feedback registry to reduce racial disparities in breast cancer care.Oncology providers' perspectives on endocrine therapy prescribing and management.
P2860
Q26785496-1B49B433-ADEB-4E5E-AB2F-BD0A2DF62DF3Q27321468-F4B69369-45F3-490F-8742-68C19194EC13Q28657951-2BA00802-041C-4836-A0A7-BDC8885A8D50Q30532682-5473BB62-3837-46B4-83F6-D54268E237A2Q33562869-11895FBE-B69B-4602-9C39-7B1152A70EA9Q33631047-45E4DD18-084E-4B33-9924-CFA223773BA6Q33677625-BFC2168A-02C0-4974-9046-0B59362CAFF3Q33756776-43881BCE-8C14-4A9C-929F-CC97403509F7Q33795923-C0B9858C-3EDA-4BDF-92F2-8B4D83908AA2Q33874887-F7ACB0C7-BD40-4521-A2B1-75E7D6CA2949Q33885999-7F834F06-1D78-4DAF-AC5E-49696D9F3B57Q34445764-D6560CE3-E2D4-4EE9-BC88-5489FF67CB3FQ34496551-7036FE67-EA38-4604-9D80-4EAFD035D6AEQ34626478-D0D24A2B-9A40-4A08-8896-C3061E9AF0A7Q35006809-A8932750-10D4-435D-AA6C-E01C9727632CQ35059403-C5E9D942-4EEC-4F75-AB99-7B29515B2488Q35127923-9D02737A-5FB0-49D4-8911-AE8A53299352Q35146054-947C625A-3E2B-4FA8-AD18-2C99CB8D2C33Q35440357-081E071A-1E21-4B60-BD28-E3DE2260F3E4Q35444531-B413263F-6A04-4264-86E4-348BEFF93729Q35849248-6C679887-5FCF-4BAD-83EA-2191F63A6E55Q36033062-22DA2EF2-22DA-4F08-B924-EEFEB054BF30Q36277429-90E926F3-EE5C-45BC-B792-756CEC2A675CQ36363405-1F4BBFBA-6AD7-45CD-973F-584A783762F3Q36406107-DFD7C324-30AA-443E-9C8E-5ADCB1A7F4DEQ36429615-9550BCA2-D2B1-434E-8C26-FF7CDDE56BC5Q36542468-4D82F13F-65B9-4186-B09A-30018F9C837EQ36556940-4B0A1F8A-955F-4C17-85F6-BB6D920D4387Q36654489-BF785F8B-A012-40EF-BF11-C85009ED99FBQ36678251-681F5F05-CABC-418A-A722-E2B04DE9038CQ36681080-AB8CD67E-538F-4906-BFCB-A67015B2D357Q36713559-B35EAC09-973F-4172-8CEA-755CA8C2AA33Q36775383-ADDBBB04-5D80-45FE-AFA9-92AAB8CC2847Q36788354-4EB0F9B2-86E7-4368-904F-14C8C7D353CBQ36979547-04DB0D63-26DA-4464-BFD4-7AAF064FF3B7Q37044668-37F72AE9-067B-40BF-ABE5-5CF2BDCBA059Q37076715-A7644210-17AB-4718-AD89-05B7A7565E12Q37146389-79072D82-EECC-4339-9093-EEC701A92459Q37305732-B74E91FB-640E-4EE9-A1FD-C51670681D1CQ37316792-A286EE47-D295-475D-B0E2-22ED93BAAAF8
P2860
Patient centered experiences in breast cancer: predicting long-term adherence to tamoxifen use.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Patient centered experiences i ...... rm adherence to tamoxifen use.
@en
Patient centered experiences i ...... rm adherence to tamoxifen use.
@nl
type
label
Patient centered experiences i ...... rm adherence to tamoxifen use.
@en
Patient centered experiences i ...... rm adherence to tamoxifen use.
@nl
prefLabel
Patient centered experiences i ...... rm adherence to tamoxifen use.
@en
Patient centered experiences i ...... rm adherence to tamoxifen use.
@nl
P2093
P1433
P1476
Patient centered experiences i ...... rm adherence to tamoxifen use.
@en
P2093
Arnold M Epstein
Jennifer L Malin
John L Adams
Katherine L Kahn
P304
P356
10.1097/01.MLR.0000257193.10760.7F
P577
2007-05-01T00:00:00Z